Inlyta revenue

In the first nine months of this year, Pfizer’s (PFE) Inlyta revenue grew ~12% YoY (year-over-year) to $226.0 million from $256.0 million. US Inlyta sales fell ~7% YoY to $88.0 million, while international Inlyta sales fell ~14% YoY to $138.0 million. Internationally, Inlyta operations declined ~16% YoY. In the third quarter, Inlyta revenue fell ~15% YoY to $71.0 million, with US and international Inlyta sales falling ~10% and ~18% YoY to $27.0 million and $44.0 million, respectively.

Pfizer’s Inlyta and Recent Developments in Its Oncology Business

Recent developments

In September, the FDA approved Pfizer’s Vizimpro as a first-line treatment of metastatic non-small cell lung cancer with an exon-19 deletion or exon-21-L858R substitution. The ARCHER 1050 trial demonstrated Vizimpro’s safety and efficacy.

Also, in October, the FDA approved Pfizer’s Talzenna (talazoparib) for treating adults with deleterious germline BRCA-mutated human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer. The new FDA approvals are set to strengthen Pfizer’s oncology portfolio, which could significantly boost the company’s revenue growth and the iShares US Pharmaceuticals ETF (IHE), of which Pfizer comprises ~10.21%.

Latest articles

If there’s one thing critics and fans agree on when it comes to Bitcoin, it’s the volatility factor. The moves are big, and timid investors need not apply.

In this year’s annual shareholder letter, Berkshire Hathaway (BRK.B) CEO Warren Buffett discussed the possibility of an “elephant-sized acquisition."

The esports industry is thriving. Let's take a look at the expected growth in esports viewership and the total available market in the space.

Today, Jeff Bezos detailed Amazon's plans for sweeping sustainability initiatives. Bezos's announcement came a day before the Global Climate Strike.

Integrated oil companies ExxonMobil and Chevron have strong upstream portfolios, which play a vital role in determining their profitabilities.

Adobe (ADBE) released its fiscal 2019 third-quarter earnings results on September 17. Overall, its third-quarter results exceeded expectations.